Avac Event
This webinar, which coincided with observances of HIV Vaccine Awareness Day (May 18th) provided an update on follow-on trials that build on the positive findings from the RV144 Thai trial; what looks hopeful in early clinical and pre-clinical science; and why the field has increasing optimism about finding effective HIV-specific antibodies, the “holy grail” of anti-HIV immune responses. As always, your comments and questions help guide the discussion.
View the full webinar here.
Avac Event
The Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO) invites you to join us for a webinar entitled “Do we need a new paradigm for HIV vaccine development?” with Dr. José Esparza who will give participants a greater understanding of some of the lessons learned after 30 years of HIV vaccine development.
This webinar will include a brief history of HIV vaccine development, some reflections about why it has been so difficult, and personal recommendations to accelerate the development of an HIV vaccine.
With José Esparza MD, PhD, formerly of the Bill & Melinda Gates Foundation; and Adjunct Professor, Institute of Human Virology, University of Maryland School of Medicine
To register contact aco-projects@icid.com
Avac Event
On May 18 every year, HIV prevention advocates around the world raise their voices about the urgent need to continue the search for a safe and effective AIDS vaccine, and especially to recognize the enormous contribution of the thousands of volunteers who have participated in vaccine trials, without which this research would not be possible.
Here is a partial list of events that happened all around the world.
Where: Bangkok, Thailand
What: Lunchtime Briefing at Mahidol University
Details: “What’s new in HIV Vaccine?” with presentations by Dr Nakorn Premsri, Dr Supachai Rerks-ngarm, Dr Soachai Nitayaphan and Dr Robert O-Connell, moderated by Professor Punnee Pitisuttithum and introduced by Dean Professor Yaowalak Sukthana.
If you want to attend: 11.30am-1.00pm, Mahidol University, School of Tropical Medicine, 5th Floor, Chalermprakiat 50 years building
Where: New York City
What: Vaccine-o-licious: Free night of entertainment and education
Details: Vaccine-o-licious is an annual event designed to spread the word about HIV Vaccine Awareness Day. The event brings together a variety of performers uniting through dance and song. Peppermint, the NYC Queen of Vaccine, will host this exciting evening of entertainment, with a little education too!
If you want to attend: 6.30-10.30pm, Santos Party House, 96 Lafayette St. Click here to reserve your free tickets.
Where: Uganda
What: National print and radio features
Details:
Where: Kenya and Uganda
What: Media, civil society and community events
Details:
Kenya
Uganda
Where: South Africa – clinical trial site communities of Nyanga and Masiphumelele
What: Community events
Details: From 18-22 May a series of events at and around research clinical trial sites will bring community stakeholders together to 1) commemorate people who have passed due to HIV related illnesses, and 2) present updates on HIV prevention research. The events will feature:
Communities will be challenged to support through participation or encourage families, neighbors and all people in society to seek to understand and rally behind clinical research.
Avac Event
AVAC is excited to be working with civil society and research partners across the globe on a number of community events to commemorate HIV Vaccine Awareness Day.
We encourage your participation if you live near any one of them! If you would like more information about an an event or if you have your own that you would like us to include on our list, please contact us at avac@avac.org.
Also a statement from the Vaccine Interest Group in Uganda was published in The New Vision and The Daily Monitor newspapers. Take a look.
See HIV Vaccine Awareness Day events below:
New Prevention Interventions and Relevance to the MSM Community in Beijing, China
Date and Location: May 18, Beijing, China
Event Organizer: Cai Lingping, China HIV/AIDS Information Network (CHAIN)
HIV Prevention Activists on Vaccines
Date and Location: Date TBD, Nairobi, Kenya
Event Organizer: Lucy Ghati, National Empowerment Network of People Living with HIV/AIDS in Kenya (NEPHAK)
Creating Awareness on HIV Vaccines Among Sex Workers
Date and Location: May 18, Nairobi, Kenya
Event Organizer: Grace Kamau, Bar Hostess Empowerment and Support Program (BHESP)
HIV Vaccines for HIV Prevention: The Past, Present and Future
Date and Location: May 17, Kisumu, Kenya
Event Organizer: Simon Odiwuor
Medical Camp Highlighting the Need for Vaccines
Date and Location: June 1, Kisumu, Kenya
Event Organizer: Dr Stella Njuguna, KEMRI-RCTP
Community HIV Vaccine Research Literacy in Jos, Nigeria
Date and Location: Date TBD, Jos, Nigeria
Event Organizer: Morenike Ukpong, The New HIV Vaccine and Microbicide Advocacy Society (NHVMAS)
HIV Prevention Roundtable
Date and Location: May 23, Lagos, Nigeria
Event Organizer: Francis Umoh, Positive Action for Treatment Access (PATA)
Civil Society Symposium on Vaccine Research
Date and Location: May 17, Cape Town, South Africa
Event Organizer: Ntando Yola, Networking HIV/AIDS Community of South Africa (NACOSA)
One-Day Workshop Raising Awareness on the Importance of Vaccines, Particularly HIV Vaccines for Adults
Date and Location: May 23, Durban, South Africa
Event Organizer: Gethwana Mahlase, Zimnandi Zonke
One-Day HIV Vaccine Awareness Day Session
Date and Location: May 17, Durban, South Africa
Event Organizer: Tabita Mahlangeni, Medical Research Council/HIV Prevention Research Unit
A Series of HIV Vaccine Community Events
Date and Location: May 17, Johannesburg, South Africa
Event Organizer: Nomampondo Barnabas, Perinatal HIV Research Unit (PHRU)
Researcher and Community Roundtable
Date and Location: May 18, Bangkok, Thailand
Event Organizer: Udom Likhitwonnawut, Thai NGO Coalition on AIDS (TNCA)
Stakeholder Roundtable Discussion on AIDS Vaccine Research in Uganda
Date and Location: May 17, Kampala, Uganda
Event Organizer: Richard Hasunira, Uganda Civil Society Coalition
A Series of Radio Segments and Community Dialogue on HIV Vaccines
Date and Location: May 16 & 18, Kampala, Uganda
Event Organizer: Moses Supercharger Nsubuga, Stigmaless Band
Real Talk: What’s This I Hear About an HIV Vaccine?
Date and Location: May 17, Los Angeles, US
Event Organizer: Kieta D. Mutepfa, UCLA CARE Center
Vaccine-o-licious
Date and Location: May 5, New York City, US
Event Organizer: DaShawn Usher, Project ACHIEVE
Biomedical Interventions for an AIDS-Free Generation – Community Forum on Local PrEP and Vaccine Research
Date and Location: May 15, Oakland, US
Event Organizer: Rob Newells, Imani Community Church
A Series of Community Events on HIV Vaccine Awareness
Date and Location: May 18, Lusaka, Zambia
Event Organizer: Clever Chilende, Treatment Advocacy and Literacy Campaign (TALC)
Media and Advocate’s Training on HIV Vaccines
Date and Location: May 16, Harare, Zimbabwe
Event Organizer: Munyaradzi Chimwara, KAIROS Zimbabwe
Sensitizing Community on the Value of HIV Vaccine Research
Date and Location: May 21, Harare, Zimbabwe
Event Organizer: Tendayi Westerhof, Womens Health, HIV and AIDS Southern Africa
Live Radio Talk Shows Focusing on Vaccines (Radio Simba, Top Radio and Radio One)
Date and Location: Staring May 14 through Week of May 20), Kampala, Uganda
Event Organizer: Dr Hannah Kibuuka and Lillian Mutengu, Makerere University Walter Reed Program
A Series of Events for Civil Society and the Media (including a Media Dialogue on HIV Vaccines)
Date and Location: May 16 & May 17, Kampala, Uganda
Event Organizer: Monica Millard and Lillian Mutengu, Makerere University Walter Reed Program
Live TV Talk Shows Focusing on Vaccines (NTV and Channel44 Television)
Date and Location: Week of May 20, Kampala, Uganda
Event Organizer: Monica Millard and Lillian Mutengu, Makerere University Walter Reed Program
Avac Event
The US National Institute of Allergy and Infectious Diseases (NIAID) and HIV Vaccine Trials Network (HVTN) accounced that the HVTN 505 AIDS vaccine clinical trial would cease immunizations early after the independent Data and Safety Monitoring Board (DSMB) determined during a scheduled interim review that the vaccine regimen being tested is not effective.
Trial investigators Scott Hammer and Madgalena Sobieszczyk were joined by statisticians Holly Janes and Peter Gilbert to discuss these results and take questions.
Avac Event
This 90-minute webinar, moderated by Rebekah Webb, provided advocates with an overview of European efforts to develop an HIV vaccine through national and EU-funded programmes. The presentations were followed by a question and answer session with the expert speakers.
Avac Event
AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.
View the program here.
For more information, click here.
WEBINARS
AIDS Vaccine Research: The latest news and conference details
This webinar featured leaders in the field providing updates on ongoing and planned efficacy trials, along with a review of the science behind neutralizing antibody research.
A recording is available here.
For background on each of these issues check out AVAC’s fact sheet series, AIDS Vaccine Science for Busy Advocates.
AVAC AT AIDS VACCINE 2012
Symposia 04: Cross-cutting Issues in Clinical Trial Design
In a symposium on cross-cutting issues in trial design, presenters offered ideas on whether and how PrEP may be added to ongoing and planned AIDS vaccine trials, and the ethical and practical challenges of defining the standard of prevention offered to trial participants as new strategies are identified. Slides are available:
Good Participatory Practice (GPP) Guidelines
HIV Vaccines & Microbicides Resource Tracking
CONFERENCE DETAILS
Each of the sessions in the conference program was webcast—see the full list here.
Our suggested webcast viewing is available here.
Additional coverage of AIDS Vaccine 2012 will appear in the forthcoming issue of Px Wire.
Avac Event
AIDS Vaccine 2013 took place from October 7–10 in Barcelona, Spain. AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the best and brightest scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.
For the full program, click here . And, much of the conference is available via webcast here.
Jauhara has worked in the public health field for more than fifteen years, with a specific focus on biomedical prevention research. She has recently joined IAVI as the Associate Director for community engagement, and she spent the past decade at Makerere University Walter Reed Project (MUWRP), where she led their community outreach efforts.
Fellowship Focus
Jauhara developed an HIV prevention research training guide for the media in Uganda to help streamline content and scope. Her training guide filled an important gap, since at the time of her Fellowship—although there had been efforts to build media capacity to report effectively on new HIV prevention research—the content and scope of such workshops was limited.
In Their Own Words
Although we haven’t developed a safe and effective vaccine yet, we have come a long way in the past decade regarding HIV prevention and treatment options, with PrEP now available in many countries and microbicides possibly on the horizon. We’ve also had many breakthrough advances in vaccine research–including the RV144 result–that give us hope. We must keep at it, and every stakeholder must play their part.
In its 16th annual report, the Resource Tracking for HIV Prevention Research & Development Working Group documents research and development spending for the calendar year 2020 and analyzes funding trends spanning twenty years.